Concord Biotech has invested Rs 6.09 crore through subscription to Right issue of shares in CLEAN MAX EVERGLADES (Clean Max) for installation of hybrid renewable energy plant in the State of Gujarat having a wind capacity of 6.6 MW and solar capacity of 3.3 MWp DC for the plant of the Company situated at Dholka. Investment in 26% equity share capital in Clean Max, renewable energy aligns with the Company`s commitment to sustainability and it`s focused efforts to address environmental challenges. By transitioning to renewable energy sources, the company will reduce its carbon footprint, contributing to global efforts to combat climate change. Additionally, renewable energy offers long-term financial benefits, including reduction in energy costs. This strategic investment reinforces the Company`s commitment to environmental responsibility, ensuring compliance with evolving environmental regulations, and supporting sustainable growth while enhancing operational efficiency. Powered by Capital Market - Live News

Net profit of Concord Biotech declined 2.13% to Rs 75.92 crore in the quarter ended December 2024 as against Rs 77.57 crore during the previous quarter ended December 2023. Sales rose 1.42% to Rs 244.22 crore in the quarter ended December 2024 as against Rs 240.80 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales244.22240.80 1 OPM %40.1143.99 - PBDT114.42116.64 -2 PBT101.15103.10 -2 NP75.9277.57 -2 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live News

Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as against Rs 81.02 crore during the previous quarter ended September 2023. Sales rose 18.23% to Rs 310.18 crore in the quarter ended September 2024 as against Rs 262.35 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales310.18262.35 18 OPM %43.1144.11 - PBDT143.65123.00 17 PBT130.34109.70 19 NP95.7481.02 18 Powered by Capital Market - Live News

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live News